This event is exclusive to Friends of Tortoise
This is a digital-only ThinkIn.
While most of society returned to normal after the pandemic, there are still half a million immunocompromised people in the UK who are trapped in their homes. Many are still shielding, still in isolation. Still unable to work, see friends or hug loved ones.
It doesn’t have to be this way. Fortunately there is a treatment called Evusheld which can protect the immunocompromised against the threat of covid. It’s a treatment developed and manufactured in the UK, and approved in 32 countries.
Evusheld could offer freedom to the half a million immunocompromised Brits who can’t leave their homes – but, for some reason, the UK government won’t authorise its use.
Join us for a special ThinkIn where we try to understand why Evusheld is being blocked in the same country that makes it, and the impact this decision is having on the people who just want their lives back.
editor and invited experts
James Harding
Editor and Co-founder
Daisy Cooper
MP
Dr Lennard Lee
Academic Clinical Lecturer in Medical Oncology at the University of Oxford
Helen Rowntree
Director of Research, Blood Cancer UK
Lord Mendelsohn
Mark Oakley
Evusheld for the UK